COMMUNIQUÉS West-GlobeNewswire

Constellation Pharmaceuticals Highlights EZH2 Inhibition Program in Prostate Cancer at Biomedical Conference
15/11/2018
CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc., (Nasdaq: CNST) a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel [...]
Exalenz Announces Third Quarter 2018 Financial Results
15/11/2018
Third quarter 2018 revenue increased 25% to $3.2 million, compared with $2.5 million in same period in 2017 Third quarter 2018 gross profit increased 60% compared to same period in 2017 MODI’IN, Israel and MANASQUAN, N. [...]
Bio-Path Holdings Reports Third Quarter 2018 Financial Results
15/11/2018
Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi [...]
Priority Review Granted to BeiGene’s New Drug Applications for Zanubrutinib and Tislelizumab in China
15/11/2018
CAMBRIDGE, Mass., and BEIJING, China, Nov. 15, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Akers Biosciences Announces Q3 2018 Earnings
15/11/2018
Sales of Flagship PIFA Heparin PF/4 Rapid Assay Products Up 16% over Q3 2017; Company Continuing to Evaluate Strategic Alternatives to Maximize Shareholder Value THOROFARE, N.J., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Akers [...]
Akari Announces Third Quarter 2018 Financial Results and Business Highlights
15/11/2018
Four ongoing clinical trial programs Two clinical programs expected to report initial data in first quarter 2019 Long-term clinical study continues to yield encouraging safety data NEW YORK and LONDON, Nov. 15, 2018 ( [...]
Auris Medical Reports Third Quarter 2018 Financial Results and Provides Business Update
15/11/2018
Positive outcomes from second Phase 1 trial with intranasal betahistine Further evidence for betahistine's preventive effects in antipsychotic-induced weight gain Progressing intranasal betahistine program towards proof [...]
World Health Organization’s “World Antibiotic Awareness Week” highlights the need for Avivagen’s products
15/11/2018
OTTAWA, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or “Corporation”), a world leader in natural alternatives to antibiotics with its OxC-beta™ technology, strongly endorses the World Health [...]
Pilot Study to Investigate a Cannabinoid Derived Drug in Dogs
15/11/2018
Tetra Bio-Pharma and Panag Pharma Advance their Veterinary Drug Pipeline ORLEANS, Ontario, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“ Tetra ” or “ TBP ”) (TSX VENTURE: TBP) (OTCQB: TBPMF) and Panag [...]
Update on financing with Silver Arch Capital Partners, LLC
15/11/2018
CALGARY, Alberta, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) ( NEO: MGW, OTCQX: MGWFF ) announces that the Silver Arch Capital Partners, LLC has retained the [...]
Saniona’s partner Cadent Therapeutics initiates Phase 2 for CAD-1883 and secures USD 40 million financing
15/11/2018
PRESS RELEASE 15 November 2018 Saniona (OMX: SANION), a leading biotech company within ion-channel research, announced today that its partner, Cadent Therapeutics, has initiated a Phase 2a study for CAD-1883 in [...]
The World's First Combined Endoscopic and Robotic-Guided Spine Surgery is Performed by Surgeons at Virginia Spine Institute
15/11/2018
Dr. Colin Haines and Dr. Christopher Good, Spine Surgeons at Virginia Spine Institute, utilize state-of-the-art technology to perform breakthrough minimally invasive robotic-guided spinal fusion with endoscopic [...]
LogicBio Announces Partnership with Children’s Medical Research Institute to Develop Next Generation Viral Vectors
15/11/2018
CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (NASDAQ: LOGC), a genome editing company focused on developing medicines to durably treat rare diseases, today announced the launch of a [...]
State-of-the-Art Cellular System Installed at The Wharf in Washington, D.C.
15/11/2018
Connectivity Wireless Solutions provides future-ready connectivity for District Wharf visitors and residents WASHINGTON, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Developers PN Hoffman and Madison Marquette announce that The [...]
Mesoblast Financial Results Webcast for Quarter Ended September 30, 2018
15/11/2018
NEW YORK and MELBOURNE, Australia, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) will report financial results for the quarter ended September 30, 2018 in a webcast beginning at 4:30 pm on [...]
HealthLynked Reports Third Quarter 2018 Financial Results
15/11/2018
HealthLynked Revenue Increased 19% Year-to-Date Compared to the Same Period in 2017 NAPLES, Fla., Nov. 15, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK ), a provider of healthcare-related technology which [...]
AC Immune Awarded Third Follow-up Grant from The Michael J. Fox Foundation for First-in-Human Study of a Positron Emission Tomography (PET) Tracer for Parkinson's Disease
15/11/2018
Grant supports next step in development of potentially first alpha-synuclein PET tracer for Parkinson's disease Start of first-in-human study of current lead is scheduled for Q1 2019 Follow-up grant marks longstanding [...]
INNATE PHARMA : Third quarter 2018 report
15/11/2018
Innate Pharma Third quarter 2018 Report Acceleration of becoming a fully integrated oncology-focused biotech company through a recent landmark deal with AstraZeneca Expansion of oncology development collaboration with [...]
INNATE PHARMA : Information financière du troisième trimestre 2018
15/11/2018
Information financiÈre du troisiÈme trimestre 2018 Accélération de la stratégie pour transformer Innate Pharma en une société de biotechnologie intégrée dédiée à l'oncologie grâce à un accord structurant avec [...]

Pages